Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Bell

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Communicable Diseases Intelligence Quarterly Report|June 17, 2003
SENTRY Antimicrobial Surveillance Program Asia-Pacific region and South AfricaJan Bell, John Turnidge
Communicable Diseases Intelligence Quarterly Report|May 17, 2007
Prevalence of antimicrobial resistances in common pathogenic Enterobacteriaceae in Australia, 2004: report from the Australian Group on Antimicrobial ResistanceJulie Pearson, John Turnidge, Clare Franklin, et al.
International Journal of Antimicrobial Agents|July 20, 2002
Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999John Turnidge, Jan Bell, Douglas J Biedenbach, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalisFlorence Depardieu, Mathias Kolbert, Hendrik Pruul, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2004
Emergence of IMP-4 metallo-beta-lactamase in a clinical isolate from AustraliaAnton Y Peleg, Clare Franklin, Jan Bell, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
VanE-type vancomycin-resistant Enterococcus faecalis clinical isolates from AustraliaLorena Abadía-Patiño, Keryn Christiansen, Jan Bell, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2007
Selection of SHV extended-spectrum-beta-lactamase-dependent cefotaxime and ceftazidime resistance in Klebsiella pneumoniae requires a plasmid-borne blaSHV geneDavid S Hammond, Tegan Harris, Jan Bell, et al.
The Journal of Infection|April 6, 2010
The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)David J Farrell, John D Turnidge, Jan Bell, et al.
Diagnostic Microbiology and Infectious Disease|December 22, 2005
Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and AustraliaRonald N Jones, Qing Li, Bruce Kohut, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 11, 2006
Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrationsKingsley P Coulthard, Daniel G Peckham, Steven P Conway, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Communicable Diseases Intelligence Quarterly Report|June 17, 2003
SENTRY Antimicrobial Surveillance Program Asia-Pacific region and South AfricaJan Bell, John Turnidge
Communicable Diseases Intelligence Quarterly Report|May 17, 2007
Prevalence of antimicrobial resistances in common pathogenic Enterobacteriaceae in Australia, 2004: report from the Australian Group on Antimicrobial ResistanceJulie Pearson, John Turnidge, Clare Franklin, et al.
International Journal of Antimicrobial Agents|July 20, 2002
Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999John Turnidge, Jan Bell, Douglas J Biedenbach, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalisFlorence Depardieu, Mathias Kolbert, Hendrik Pruul, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2004
Emergence of IMP-4 metallo-beta-lactamase in a clinical isolate from AustraliaAnton Y Peleg, Clare Franklin, Jan Bell, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
VanE-type vancomycin-resistant Enterococcus faecalis clinical isolates from AustraliaLorena Abadía-Patiño, Keryn Christiansen, Jan Bell, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2007
Selection of SHV extended-spectrum-beta-lactamase-dependent cefotaxime and ceftazidime resistance in Klebsiella pneumoniae requires a plasmid-borne blaSHV geneDavid S Hammond, Tegan Harris, Jan Bell, et al.
The Journal of Infection|April 6, 2010
The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)David J Farrell, John D Turnidge, Jan Bell, et al.
Diagnostic Microbiology and Infectious Disease|December 22, 2005
Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and AustraliaRonald N Jones, Qing Li, Bruce Kohut, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 11, 2006
Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrationsKingsley P Coulthard, Daniel G Peckham, Steven P Conway, et al.
Pageof 2